Company & Sponsor Intelligence
Technische Universität Dresden
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting0
Completed2
Countries1
Therapeutic footprint
out_of_scopeparkinsonssubstance_use
Indexed studies
NCT01076608DETECT-Diabetes Cardiovascular Risk-Evaluation: Targets and Essential Data for Commitment of Treatment
out_of_scope · COMPLETED
out_of_scope · COMPLETED
NCT01858818Project 4: Acute Effects of Alcohol on Learning and Habitization in Healthy Young Adults
substance_use · GermanyCOMPLETED
substance_use · GermanyCOMPLETED
NCT02275884Pharmacologically Active Constituents of Chocolate and Their Symptomatic Effects in Patients With Idiopathic Parkinson's Disease
parkinsons · GermanyNA
parkinsons · GermanyNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →